GUPEA >
Sahlgrenska Academy / Sahlgrenska akademin >
Institute of Medicine / Institutionen för medicin >
Doctoral Theses / Doktorsavhandlingar Institutionen för medicin >

Adherence to lipid-lowering medications and cardiovascular disease prevention in type 2 diabetes mellitus


Please use this identifier to cite or link to this item: http://hdl.handle.net/2077/56923

Files in This Item:

File Description SizeFormat
gupea_2077_56923_1.pdfThesis frame1850KbAdobe PDF
View/Open
gupea_2077_56923_2.pdfAbstract157KbAdobe PDF
View/Open
gupea_2077_56923_4.pdfCover3546KbAdobe PDF
View/Open
Title: Adherence to lipid-lowering medications and cardiovascular disease prevention in type 2 diabetes mellitus
Authors: Karlsson, Sofia Axia
Issue Date: 7-Nov-2018
University: University of Gothenburg. Sahlgrenska Academy.
Institution: Institute of Medicine. Department of Public Health and Community Medicine
Parts of work: I. Karlsson SA, Hero C, Eliasson B, Franzén S, Svensson AM, Miftaraj M, Gudbjörnsdottir S, Eeg-Olofsson K, Andersson Sundell K. Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study. Pharmacoepidemiology and Drug Safety 2017; 26(10): 1220-1232.
VIEW ARTICLE


II. Karlsson SA, Hero C, Svensson AM, Franzén S, Miftaraj M, Gudbjörnsdottir S, Eeg-Olofsson K, Eliasson B, Andersson Sundell K. Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study. BMJ Open 2018; 8(3): e020309
VIEW ARTICLE


III. Karlsson SA, Franzén S, Svensson AM, Miftaraj M, Eliasson B, Andersson Sundell K. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register. Submitted.

IV. Karlsson SA, Eliasson, B, Franzén S, Miftaraj M, Svensson AM, Andersson Sundell K. Associations between patients’ and healthcare providers’ adherence to lipid-lowering medications and risk of cardiovascular events and mortality in patients with type 2 diabetes mellitus in Sweden. Manuscript.
Date of Defence: 2018-11-30
Disputation: Fredagen den 30 november 2018, kl. 9.00, rum 2118, Arvid Wallgrens Backe, hus 2, Göteborg.
Degree: Doctor of Philosophy (Pharmaceutical science)
Publication type: Doctoral thesis
Keywords: medication adherence
refill adherence
medication persistence
pharmacoepidemiology
lipid-lowering medications
type 2 diabetes mellitus
cardiovasular disease
all-cause mortality
cardiovascular mortality
guideline adherence
Abstract: Background and aims: Globally, cardiovascular disease (CVD) is the major cause of death among patients with type 2 diabetes mellitus (T2DM). Improved control of LDL cholesterol with lipid-lowering medications and patients’ adherence to such medications have been shown associate with lower risk of CV events and mortality among T2DM patients. The impact of healthcare providers’ adherence to guidelines regarding prescription for lipid-lowering medications is unclear. This thesis aimed to assess... more
ISBN: 978-91-7833-155-0 (PRINT)
978-91-7833-156-7 (PDF)
URI: http://hdl.handle.net/2077/56923
Appears in Collections:Doctoral Theses from Sahlgrenska Academy
Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
Doctoral Theses / Doktorsavhandlingar Institutionen för medicin

 

 

© Göteborgs universitet 2011